Study of Gemcabene in Adults With FPLD

NCT03508687 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Familial Partial Lipodystrophy
Hypertriglyceridemia
Fatty Liver
NASH - Nonalcoholic Steatohepatitis

Interventions

DRUG: 300mg Gemcabene
DRUG: 600mg Gemcabene

Sponsor

Elif Oral